Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Gastpar

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
International Journal of Psychiatry in Clinical Practice|July 2, 2013
Hypericum extract WS ® 5570 for depression--an overviewMarkus Gastpar
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2004
Buprenorphine in the treatment of opioid dependenceEugen Davids, Markus Gastpar
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 10, 2002
[Acute treatment of opiate addiction in patients in 2001]Markus Gastpar, Gerhard Reymann
Psychiatrische Praxis|May 28, 2003
[Attention-deficit/hyperactivity disorder and substance abuse]Eugen Davids, Markus Gastpar
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2005
Attention deficit hyperactivity disorder and borderline personality disorderEugen Davids, Markus Gastpar
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
Antipsychotic treatment of psychosis associated with multiple sclerosisEugen Davids, Ulrike Hartwig, Markus Gastpar
Psychiatrische Praxis|May 21, 2004
[The visit at home by a social worker of a psychiatric outpatient clinic]Markus Banger, Monika Wellnitz, Markus Gastpar
Basic & Clinical Pharmacology & Toxicology|December 10, 2019
The effect of perazine on the CYP2D6 and CYP2C19 phenotypes as measured by the dextromethorphan and mephenytoin tests in psychiatric patientsPierre Baumann, Chin B Eap, Markus Gastpar
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 2, 2006
Psychotropic drug prescription in a psychiatric university hospital in GermanyEugen Davids, Christine Bunk, Michael Specka, et al.
Psychiatrische Praxis|July 23, 2003
[Descriptive analysis of drug-related deaths over a 5-year period]Eugen Davids, Uwe Reinhold, Clemens Rösinger, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Psychiatry in Clinical Practice|July 2, 2013
Hypericum extract WS ® 5570 for depression--an overviewMarkus Gastpar
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 2, 2004
Buprenorphine in the treatment of opioid dependenceEugen Davids, Markus Gastpar
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|August 10, 2002
[Acute treatment of opiate addiction in patients in 2001]Markus Gastpar, Gerhard Reymann
Psychiatrische Praxis|May 28, 2003
[Attention-deficit/hyperactivity disorder and substance abuse]Eugen Davids, Markus Gastpar
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 14, 2005
Attention deficit hyperactivity disorder and borderline personality disorderEugen Davids, Markus Gastpar
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 28, 2004
Antipsychotic treatment of psychosis associated with multiple sclerosisEugen Davids, Ulrike Hartwig, Markus Gastpar
Psychiatrische Praxis|May 21, 2004
[The visit at home by a social worker of a psychiatric outpatient clinic]Markus Banger, Monika Wellnitz, Markus Gastpar
Basic & Clinical Pharmacology & Toxicology|December 10, 2019
The effect of perazine on the CYP2D6 and CYP2C19 phenotypes as measured by the dextromethorphan and mephenytoin tests in psychiatric patientsPierre Baumann, Chin B Eap, Markus Gastpar
Progress in Neuro-Psychopharmacology & Biological Psychiatry|June 2, 2006
Psychotropic drug prescription in a psychiatric university hospital in GermanyEugen Davids, Christine Bunk, Michael Specka, et al.
Psychiatrische Praxis|July 23, 2003
[Descriptive analysis of drug-related deaths over a 5-year period]Eugen Davids, Uwe Reinhold, Clemens Rösinger, et al.
Pageof 6